Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03810066
Title Exploring the Theragnostic Value of Osimertinib in EGFR-mutated Lung Cancer (THEROS)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Martin Schuler, Prof. Dr. med.
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Prof. Dr. med. Martin Schuler Essen NRW 45147 Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field